The AHA May 16 urged the Department of Commerce to consider tariff exceptions for critical minerals and derivative products used for medical purposes. Critical minerals have many medical uses, such as for magnetic resonance imaging, computerized tomography, positron emission tomography, radiopharmaceuticals and radiation therapy equipment.  
 
“Tariffs on critical minerals could have a particularly significant impact on complex medical devices that are higher cost and lower volume, in part due to requiring specialized parts and customization to meet the needs of health care providers,” the AHA wrote. “A recent survey found that 82% of health care experts expect tariff-related expenses to raise hospital costs by at least 15%, and 90% of supply chain professionals expect procurement disruptions. Given that hospital payments are set by government and private payer contracts, the costs would be borne by hospitals directly.” 

Headline
The New York Times published a letter to the editor May 16 by AHA President and CEO Rick Pollack that responds to a May 4 op-ed that claimed hospitals are…
Headline
The Food and Drug Administration announced May 6 that it is aware of a shortage of neurosurgical patties, sponges and strip devices across the U.S. due to…
Headline
An AHA blog says an essay published in The New York Times wrongly frames hospitals as the leading “culprit” behind rising health care costs. “It…
Blog
Public
A May 4 guest essay published in The New York Times frames hospitals as the leading “culprit” behind rising health care costs. It reduces a complex health…
Headline
The Health Sector Coordinating Council’s Cybersecurity Working Group has released a guide on third-party artificial intelligence risk and AI supply…
Headline
A Health Affairs report published April 6 examined how changes in patient cost-sharing liability can impact hospital finances. The study found that…